Turnstone Biologics Corp Stock Today
| TSBX Stock | 0.41 0.01 2.38% |
PerformanceVery Weak
| Odds Of DistressHigh
|
Turnstone Biologics is trading at 0.41 as of the 23rd of March 2025; that is 2.38 percent decrease since the beginning of the trading day. The stock's open price was 0.42. Turnstone Biologics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Moving together with Turnstone Stock
Moving against Turnstone Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Turnstone Stock Highlights
| CEO President | Dr MBA |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Turnstone Biologics Corp (TSBX) is traded on NASDAQ Exchange in USA. It is located in 9310 Athena Circle, La Jolla, CA, United States, 92037 and employs 81 people. Turnstone Biologics is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.39 M. Turnstone Biologics Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 23.13 M outstanding shares of which 306.52 K shares are at this time shorted by private and institutional investors with about 2.36 trading days to cover.
Turnstone Biologics generates negative cash flow from operations
Check Turnstone Biologics Probability Of Bankruptcy
Ownership AllocationTurnstone Biologics Corp shows a total of 23.13 Million outstanding shares. Over half of Turnstone Biologics' outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Turnstone Ownership Details
Turnstone Biologics Corp Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Turnstone Biologics market risk premium is the additional return an investor will receive from holding Turnstone Biologics long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0038 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | 0.3499 | |||
| Treynor Ratio | (0.14) |
Turnstone Stock Against Markets
Turnstone Biologics Corporate Management
| Ines MD | Senior Development | Profile | |
| Michael Fitch | Senior Manufacturing | Profile | |
| Vijay MBA | Interim Officer | Profile | |
| Campisi Esq | Chief Officer | Profile | |
| David Stojdl | Senior Discovery | Profile |
Additional Tools for Turnstone Stock Analysis
When running Turnstone Biologics' price analysis, check to measure Turnstone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Turnstone Biologics is operating at the current time. Most of Turnstone Biologics' value examination focuses on studying past and present price action to predict the probability of Turnstone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Turnstone Biologics' price. Additionally, you may evaluate how the addition of Turnstone Biologics to your portfolios can decrease your overall portfolio volatility.